Naveed Sattar is an academic (active clinically) experienced in biomarker studies/trials investigating the causes (environmental and biological) and links between diabetes, obesity and heart disease. He has published over 700 papers, has received several national and international prizes for his research, and is amongst the most highly cited clinical academics in the world according to Thomson Reuters in 2016.
He has been on several guideline committees including Joint British Societies 3 CVD prevention recommendations, SIGN obesity and CVD prevention guidelines (as Chair), and European CVD prevention guidelines. He is currently involved in several lifestyle and drug trials in diabetes and CVD and leads on biomarker initiatives in other trials. He is also on editorial or international advisory boards for Diabetologia, Lancet Diabetes and Endocrinology, BMC Medicine and UK Biobank, and is an Associate Editor for Circulation.